Report of Foreign Issuer (6-k)

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of September 2018

 

Commission File Number 001-37381

MEDIGUS   LTD.
(Translation of registrant’s name into English)

Omer Industrial Park, No. 7A, P.O. Box 3030, Omer 8496500, Israel

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒   Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):   ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):   ☐

 

 

 

 

EXPLANATORY NOTE

On September 6, 2018, the Company issued a press release titled: “Institutional Shareholder Services (ISS), Leading Proxy Advisor, Recommends Medigus Shareholders Vote “FOR” all Medigus’ Director Nominees.” A copy of this press release is furnished herewith as exhibit 99.1.

 

 

 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	MEDIGUS LTD.
Date: September 6, 2018	By:	/s/ Oded Yatzkan
		Oded Yatzkan
		Chief Financial Officer

 

 

 

 

EXHIBIT INDEX  

Exhibit		Description
99.1		Press release titled: “Institutional Shareholder Services (ISS), Leading Proxy Advisor, Recommends Medigus Shareholders Vote “FOR” all Medigus,’ dated September 6, 2018.